Thursday, September 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Inter Parfums Shares Face Pressure as Analysts Adjust Outlook

Robert Sasse by Robert Sasse
September 11, 2025
in Analysis, Consumer & Luxury, Earnings
0
Inter Parfums Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Fragrance and cosmetics company Inter Parfums finds itself navigating turbulent market conditions following a series of analyst downgrades and disappointing quarterly results. The stock has entered a discernible downward trajectory, marked by notable price declines and revised projections from financial institutions.

Market Experts Apply the Brakes

Equity research firm Oddo BHF recently adjusted its position on Inter Parfums, reducing its price target from €38 to €34. While the firm maintained its “Neutral” rating on the stock, this revision contributed to an immediate 3.8% drop in the share price. This analyst action was precipitated by interim financial results indicating a softening in business volumes. Since the start of the year, the stock has declined by 13.5%.

A more optimistic counterpoint comes from Berenberg, which reaffirmed its “Buy” recommendation with a €43 price objective. Their analysts acknowledged headwinds for the second half of the year, citing increased tariff expenses and a less favorable US dollar exchange rate. However, they emphasized the company’s underlying strengths, including a powerful brand portfolio, minimal debt levels, and a consistent management team.

Second Quarter Performance Falls Short of Forecasts

The company’s financial results for the second quarter of its 2025 fiscal year failed to meet market expectations. Earnings per share (EPS) came in at $0.99, significantly below the consensus forecast of $1.21. Revenue also missed the mark, reaching $334 million against projections of $357.56 million. This earnings announcement triggered a further 2.07% decrease in the stock’s value.

Should investors sell immediately? Or is it worth buying Inter Parfums?

Despite these setbacks, several positive indicators emerged from the report:
* The gross margin expanded by 170 basis points to a healthy 66.2%
* Year-to-date operating income saw a modest 1% increase
* Net sales for the first six months climbed 1% to $673 million

A regional breakdown reveals a mixed performance. European sales grew by 6% in the quarter, fueled by robust demand for key brands such as Lacoste (+59%) and Coach (+42%). In stark contrast, sales in the US market contracted by 20%, a drop primarily attributed to the termination of the Dunhill fragrance license.

Maintaining Guidance with a Focus on Holiday Sales

In spite of recent challenges, Inter Parfums’ leadership has reaffirmed its full-year guidance for 2025, projecting revenue of $1.51 billion and EPS of $5.35. The company’s strategy hinges on leveraging its established brands, launching new product innovations, and capitalizing on the critical year-end holiday shopping season. A major initiative includes the launch of its new proprietary brand, Solférino, which will feature a line of ten niche fragrances.

Governance Changes with Board Expansion

During a recent shareholder meeting, investors approved a proposal to increase the size of the company’s supervisory board from nine to eleven members. This expansion welcomes two new appointees: Patrick Bousquet-Chavanne, who brings 35 years of consumer goods expertise, and Hervé Bouillonnec, the Chief Commercial Officer of Interparfums USA.

Ad

Inter Parfums Stock: Buy or Sell?! New Inter Parfums Analysis from September 11 delivers the answer:

The latest Inter Parfums figures speak for themselves: Urgent action needed for Inter Parfums investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 11.

Inter Parfums: Buy or sell? Read more here...

Tags: Inter Parfums
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Kearny Stock
Analysis

Kearny Stock: A Battle Between Technicals and Insider Conviction

September 11, 2025
Block Stock
Analysis

Block Stock Gains Momentum from Legal Victory and Youth Market Push

September 11, 2025
Cue Biopharma Stock
Analysis

Cue Biopharma: A High-Stakes Investment With 400% Upside Potential

September 11, 2025
Next Post
Overstock Stock

Rebranding Raises Questions About Bed Bath & Beyond's Future Direction

Daqo New Energy Stock

Analyst Confidence Soars for Daqo New Energy Despite Quarterly Loss

Certara Stock

Can Certara's Market Leadership in Biosimulation Spark a Stock Revival?

Recommended

AI advertisings

Unlocking the Power of Personalized Advertising: The Future of AI in Brand Promotion

2 years ago
MMP stock news

IFP Advisors Inc Makes Headlines with Major Reduction in Hut 8 Mining Corp Holdings

2 years ago
Livent Stock

Rio Tinto’s Lithium Power Play: How a $6.7B Acquisition Reshapes the Battery Materials Race

3 weeks ago
Cellectar Stock

Cellectar Biosciences Gains Momentum with Clinical Progress and Strategic Initiatives

3 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom C Coinbase DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF MSFT NIO Nvidia Opendoor Oracle Palantir Red Cat Robinhood Rocket Lab USA Salesforce SMCI Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics
No Result
View All Result

Highlights

Acadia Realty Faces Technical Hurdles Despite Strong Analyst Confidence

Navigating Challenges: Chemours’ Strategic Pivot Amid Mixed Results

Mixed Signals for Cullen/Frost Bankers Despite Strong Quarterly Performance

Nio’s Billion-Dollar Equity Raise Sends Stock Tumbling

Strategic Expansion and Financial Restructuring Propel Light & Wonder Forward

TAL Education’s Mixed Signals: Strong Fundamentals Meet Market Skepticism

Trending

Kearny Stock
Analysis

Kearny Stock: A Battle Between Technicals and Insider Conviction

by Felix Baarz
September 11, 2025
0

The financial services provider Kearny finds itself at a critical juncture, caught between conflicting market forces. Despite...

Block Stock

Block Stock Gains Momentum from Legal Victory and Youth Market Push

September 11, 2025
Cue Biopharma Stock

Cue Biopharma: A High-Stakes Investment With 400% Upside Potential

September 11, 2025
Acadia Realty Stock

Acadia Realty Faces Technical Hurdles Despite Strong Analyst Confidence

September 11, 2025
Chemours Stock

Navigating Challenges: Chemours’ Strategic Pivot Amid Mixed Results

September 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Kearny Stock: A Battle Between Technicals and Insider Conviction September 11, 2025
  • Block Stock Gains Momentum from Legal Victory and Youth Market Push September 11, 2025
  • Cue Biopharma: A High-Stakes Investment With 400% Upside Potential September 11, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com